by @accesswire on 20 Jun 2022, 10:45
Empower Clinics Unveils Medisure Brand In the United States
Empower rebrands medical divison in the U.S. and accelerates access to the largest hospitals, medical centers and cruiseship opportunites
VANCOUVER, BC / ACCESSWIRE / June 20, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company offering services in the U.S. and Canada - announced a corporate rebrand of its medical diagnostics laboratory business in the U.S. to Medisure Laboratory, and opens opportunities to the largest healthcare centers in the state of Texas, and leverages its cruiseship connections to the largest ports in the U.S.
The new brand marks an important milestone in the evolution of Empower's presence in the U.S. healthcare market. It represents a fresh and forward-looking approach to the healthcare community, leveraging the Medisure brand as a leading medical device and testing company, to access and support the largest hospital networks with laboratory services in the state of Texas, the cruiseship industry, and film & television productions.
With the company's experience and reputation, and deep connections to major cruiseline's, Empower and its accredited laboratory in Texas, have expanded its service offering to key ports in the southern U.S. As a COLA and CLIA accredited laboratory, the company can provide testing and healthcare services to key industries such as film & television, that require testing and healthcare management solutions.
"The Medisure brand is strong, and embodies the energy and growth that we have for our business in the U.S. market." stated Steven McAuley, Chairmain and CEO, "Launching Medisure Labs in the U.S. and utilizing our investments just makes sense, it opens new doors, allows us to bring products to market and grow more rapidly. With Medisure Labs, we have a proven brand serving many thousands of patients, that is primed to succeed in the world's largest healthcare market."
Immediate plans for Medisure include researching, applying for and securing additional U.S. Federal Drug and Administration (FDA) certifications to allow for the sale of its medical devices in the U.S. Medisure is also upgrading its quality managements systems to expedite the certification process. The company has advanced its offers to the cruiseship industry and to film & television productions.
The new website for Medisure Laboratory is www.medisurelabs.com
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
Steven McAuley CEO
Business Development & Communications
Spread the love. Be the first to like this post!
Recent EPWCF News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/06/2022 06:20:21 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/03/2022 10:07:29 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/27/2022 08:48:52 PM
- Royal Caribbean Lays Keel for New Ship • TipRanks • 04/05/2022 06:26:06 PM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM